Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer

Changqing Zeng(Washington University in St. Louis), Robert H. Mach(Washington University in St. Louis)
British Journal of Cancer
October 1, 2013
Cited by 35


Related Papers